216.73.217.64

CVE-2025-50675

· Published 07/08/2025 19:15 · Modified 07/08/2025 21:26

Labels: CVE-2025-50675 2025-08-07CVE-2025-50675[email protected]

Essential information

Published
07/08/2025 19:15
Modified
07/08/2025 21:26
Author
Creator
CISA KEV
No
CWE

Description

GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation.

NVD status

Status
Awaiting Analysis — CVE has been recently published to the CVE List and has been received by the NVD.
Source
[email protected]
NVD
View on NVD

Affected products (CPE)

ProductCPE
gpmaw / gpmaw cpe:2.3:a:gpmaw:gpmaw:*:*:*:*:*:*:*:*

References